Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia

Blood

Volumn 97, Issue 2, 2001, Pages 442-448

  Piron, Maude ^b   Loo, Martine ^b   Gothot, André ^b   Tassin, Françoise ^b   Fillet, Georges ^b   Beguin, Yves ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEME; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL REGENERATION; CONTROLLED STUDY; DRUG EFFECT; ERYTHROBLAST; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; HEMATOCRIT; HEMATOPOIESIS; INHIBITION KINETICS; IRON OVERLOAD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REFRACTORY ANEMIA; RETICULOCYTE;

EID: 0035863747     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.2.442     Document Type: Article

References (37)

1. Use of recombinant human erythropoietin outside the setting of uremia
2. The effect of erythropoietin in normal healthy volunteers and pediatric patients with burn injuries
3. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers
4. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: The importance of iron availability in optimizing response
5. Rh-erythropoietin stimulates immature reticulocyte release in man
6. Epoetin enhances erythropoiesis in normal men undergoing repeated phlebotomies
7. Use of recombinant human erythropoletin in allogeneic bone marrow transplant donor/recipient pairs
8. A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects
9. A quantitative bioassay for erythropoietin, using mouse bone marrow
10. Thiazole orange: A new dye for reticulocyte analysis
11. Transferrin receptors in rat plasma
12. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin
13. The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply
14. Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men
15. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity
16. Age-related differences in erythropoietic response to recombinant human erythropoietin: Comparison in adult and infant rhesus monkeys
17. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: Iron-deficient erythropoiesis in iron-replete subjects
18. Serum erythropoietin (ESF) titers in anemia
19. Serum erythropoietin titers in hematological malignancies and related diseases
20. Red blood cell precursor mass as an independent determinant of serum erythropoietin level
21. Erythropoietin consumption during stimulated erythropoiesis
22. Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation
23. The biology of stress erythropoiesis and erythropoietin production
24. Depression of stimulated erythropoietin production in mice with enhanced erythropoiesis
25. Unexpected hypoxia-dependent erythropoietin secretion during experimental conditions not affecting tissue oxygen supply/demand ratio
26. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects
27. Mechanism for the nonlinear pharmacokinetics of erythropoietin in rats
28. Erythroid hypoplasia and anemia following administration of recombinant human erythropoietin to two horses
29. Mechanistic options of erythropoietin-stimulated erythropoiesis
30. Mutual inhibition of murine erythropoiesis and granulopoiesis during combined erythropoietin, granulocyte colony-stimulating factor, and stem cell factor administration: In vivo interactions and dose-response surfaces
31. Anemia induced in splenectomized mice by administration of rhG-CSF
32. Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat
33. Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: Correlation of platelet count with erythropoietic activity and iron parameters
34. Large, chronic doses of erythropoietin cause thrombocytopenia in mice
35. Megakaryocytic and erythrocytic cell lines share a common precursor cell
36. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow
37. Erythropoietin and platelet production